赛科希德收盘上涨1.06%，滚动市盈率27.85倍，总市值29.43亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Saikohide, indicating a decline in revenue and profit compared to the previous year [1][2] - As of August 8, Saikohide's closing price was 27.73 yuan, with a rolling PE ratio of 27.85, marking a new low in 167 days, and a total market capitalization of 2.943 billion yuan [1] - The average PE ratio for the medical device industry is 55.70, with a median of 39.08, positioning Saikohide at 57th place within the industry [1][2] Group 2 - As of March 31, 2025, Saikohide had 6,725 shareholders, an increase of 1,118 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The company's main business focuses on the development, production, and sales of diagnostic instruments, reagents, and consumables in the field of thrombosis and hemostasis [1] - In the latest quarterly report for Q1 2025, Saikohide reported revenue of 68.6393 million yuan, a year-on-year decrease of 9.47%, and a net profit of 23.1329 million yuan, down 23.98%, with a gross profit margin of 62.49% [1]